Voyager Therapeutics (NASDAQ:VYGR) Receives “Outperform” Rating from Wedbush

Wedbush reiterated their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report published on Tuesday morning,RTT News reports. Wedbush currently has a $9.00 price target on the stock, down from their prior price target of $11.00. Several other brokerages have also recently issued reports on VYGR. Cantor Fitzgerald started coverage […]